Mary Reumuth, CFO of KALA Bio Inc. ($KALA), made four open market sales of company stock over the past year, totaling about $52,800. Her most recent sale occurred on October 23, 2025. These transactions rank her 10,333rd among 11,678 insiders by sale value, well below the average of $8.6 million per insider and 6.4 transactions. She reported no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 22, 2025 | KALA BIO, Inc. | $KALA | Reumuth Mary | CHIEF FINANCIAL OFFICER | S | Common Stock | 32230 | $0.83 | 29,873.0000 | 7,042,457 | 51.90% | 0.46% |
| Oct. 23, 2025 | KALA BIO, Inc. | $KALA | Reumuth Mary | CHIEF FINANCIAL OFFICER | S | Common Stock | 967 | $0.82 | 28,906.0000 | 7,042,457 | 3.24% | 0.01% |
| June 24, 2025 | KALA BIO, Inc. | $KALA | Reumuth Mary | CHIEF FINANCIAL OFFICER | S | Common Stock | 3631 | $4.01 | 62,100.0000 | 6,345,869 | 5.52% | 0.06% |
| June 3, 2025 | KALA BIO, Inc. | $KALA | Reumuth Mary | CHIEF FINANCIAL OFFICER | S | Common Stock | 2850 | $3.74 | 65,731.0000 | 6,345,869 | 4.16% | 0.04% |
| Jan. 6, 2025 | KALA BIO, Inc. | $KALA | Reumuth Mary | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 45200 | $0.00 | 45,200.0000 | 3,796,047 | 9999.99% | 1.19% |
| Jan. 6, 2025 | KALA BIO, Inc. | $KALA | Reumuth Mary | CHIEF FINANCIAL OFFICER | S | Common Stock | 1706 | $7.63 | 68,581.0000 | 3,796,047 | 2.43% | 0.04% |
| Jan. 6, 2025 | KALA BIO, Inc. | $KALA | Reumuth Mary | CHIEF FINANCIAL OFFICER | A | Common Stock | 10100 | $0.00 | 70,287.0000 | 3,796,047 | 16.78% | 0.27% |
| June 26, 2024 | KALA BIO, Inc. | $KALA | Reumuth Mary | CHIEF FINANCIAL OFFICER | S | Common Stock | 4163 | $4.75 | 60,187.0000 | 2,813,210 | 6.47% | 0.15% |
| May 31, 2024 | KALA BIO, Inc. | $KALA | Reumuth Mary | CHIEF FINANCIAL OFFICER | S | Common Stock | 1786 | $6.09 | 64,350.0000 | 2,813,210 | 2.70% | 0.06% |
| Jan. 4, 2024 | KALA BIO, Inc. | $KALA | Reumuth Mary | CHIEF FINANCIAL OFFICER | A | Common Stock | 4600 | $0.00 | 67,363.0000 | 2,432,008 | 7.33% | 0.19% |
| Jan. 4, 2024 | KALA BIO, Inc. | $KALA | Reumuth Mary | CHIEF FINANCIAL OFFICER | S | Common Stock | 1227 | $6.74 | 66,136.0000 | 2,432,008 | 1.82% | 0.05% |
| Jan. 4, 2024 | KALA BIO, Inc. | $KALA | Reumuth Mary | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 20500 | $0.00 | 20,500.0000 | 2,432,008 | 9999.99% | 0.84% |